Jeune syndrome and liver disease: Report of three cases treated with ursodeoxycholic acid
β Scribed by Labrune, Philippe; Fabre, Monique; Trioche, Pascale; Estournet-Mathiaud, Brigitte; Grangeponte, Marie-Claire; Rambaud, Caroline; Maurage, Chantal; Bernard, Olivier
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 33 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
β¦ Synopsis
Three children with Jeune syndrome (asphyxiating thoracic dystrophy) had clinical and laboratory evidence of liver disease. In two patients the disease evolved to biliary cirrhosis, whereas in the third it was recognized when extensive fibrosis was developing. In the three patients, treatment with ursodeoxycholic acid appeared to control the progression of the hepatic dysfunction. Am.
π SIMILAR VOLUMES
Tumor necrosis factor alpha (TNF-a) inhibitors improve inflammatory diseases such as Crohn's disease (CD). However, these biologicals may induce infections, neoplasms, or autoimmune diseases. Cutaneous side effects have been reported, including dermatitis, psoriasis-like rash, and vasculitis. 1 We r
## Background: BehΓ§et's disease has rarely been reported in association with myelodysplastic syndromes (mds). increased production of reactive oxygen species (ros) by neutrophils has a primary role in the pathogenesis of behΓ§et's disease. however, decreased production of ros by neutrophils has freq